SCPH Financial Statements

Balance sheet, income statement, cash flow, and dividends for Scpharmaceuticals Inc (SCPH).


$177.14M Market Cap.

As of 03/19/2025 5:00 PM ET (MRY) • Disclaimer

SCPH Market Cap. (MRY)


SCPH Shares Outstanding (MRY)


SCPH Assets (MRY)


Total Assets

$107.52M

Total Liabilities

$94.20M

Total Investments

$0

SCPH Income (MRY)


Revenue

$36.33M

Net Income

-$85.15M

Operating Expense

$89.75M

SCPH Cash Flow (MRY)


CF Operations

-$70.54M

CF Investing

$29.30M

CF Financing

$70.08M

SCPH Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SCPH Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$107,519,000 (13.80%)

$94,479,000 (-23.93%)

$124,195,000 (57.14%)

$79,037,000 (-27.52%)

Assets Current

$105,849,000 (13.89%)

$92,938,000 (-24.63%)

$123,308,000 (57.53%)

$78,275,000 (-27.41%)

Assets Non-Current

$1,670,000 (8.37%)

$1,541,000 (73.73%)

$887,000 (16.40%)

$762,000 (-37.64%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$13,320,000 (-64.21%)

$37,218,000 (-48.62%)

$72,433,000 (28.27%)

$56,470,000 (-31.28%)

Property Plant & Equipment Net

$1,329,000 (-8.91%)

$1,459,000 (135.32%)

$620,000 (29.44%)

$479,000 (-47.25%)

Cash & Equivalents

$75,655,000 (61.61%)

$46,814,000 (-34.29%)

$71,243,000 (-4.31%)

$74,450,000 (3.40%)

Accumulated Other Comprehensive Income

$0 (0%)

-$1,000 (-103.13%)

$32,000 (3300.00%)

-$1,000 (-200.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$29,199,000 (-38.04%)

$47,125,000 (4565.84%)

$1,010,000 (-96.96%)

Investments Current

$0 (0%)

$29,199,000 (-38.04%)

$47,125,000 (4565.84%)

$1,010,000 (-96.96%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$13,903,000 (57.27%)

$8,840,000 (618.70%)

$1,230,000 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$11,721,000 (161.10%)

$4,489,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,883,000 (-2.95%)

$4,001,000 (163.57%)

$1,518,000 (179.04%)

$544,000 (-67.35%)

Accumulated Retained Earnings (Deficit)

-$366,494,000 (-30.26%)

-$281,346,000 (-24.19%)

-$226,536,000 (-19.42%)

-$189,698,000 (-17.34%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$79,562,000 (97.58%)

$40,269,000 (7.76%)

$37,368,000 (111.90%)

$17,635,000 (-12.72%)

Debt Current

$239,000 (35.80%)

$176,000 (-68.96%)

$567,000 (-94.48%)

$10,281,000 (258.47%)

Debt Non-Current

$79,323,000 (97.85%)

$40,093,000 (8.95%)

$36,801,000 (400.42%)

$7,354,000 (-57.58%)

Total Liabilities

$94,199,000 (64.51%)

$57,261,000 (10.62%)

$51,762,000 (129.37%)

$22,567,000 (-16.04%)

Liabilities Current

$14,876,000 (13.26%)

$13,134,000 (77.10%)

$7,416,000 (-50.05%)

$14,846,000 (59.27%)

Liabilities Non-Current

$79,323,000 (79.76%)

$44,127,000 (-0.49%)

$44,346,000 (474.36%)

$7,721,000 (-56.02%)

SCPH Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$36,332,000 (167.28%)

$13,593,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$11,361,000 (198.11%)

$3,811,000 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$77,649,000 (45.49%)

$53,369,000 (158.77%)

$20,624,000 (110.79%)

$9,784,000 (-16.97%)

Research & Development Expense

$12,098,000 (2.45%)

$11,809,000 (-23.97%)

$15,533,000 (-3.15%)

$16,039,000 (-11.63%)

Operating Expenses

$89,747,000 (37.70%)

$65,178,000 (80.26%)

$36,157,000 (40.02%)

$25,823,000 (-13.73%)

Interest Expense

$7,570,000 (-6.81%)

$8,123,000 (146.00%)

$3,302,000 (28.23%)

$2,575,000 (-0.46%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$85,148,000 (-55.35%)

-$54,810,000 (-48.79%)

-$36,838,000 (-31.40%)

-$28,034,000 (12.96%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$85,148,000 (-55.35%)

-$54,810,000 (-48.79%)

-$36,838,000 (-31.40%)

-$28,034,000 (12.96%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$85,148,000 (-55.35%)

-$54,810,000 (-48.79%)

-$36,838,000 (-31.40%)

-$28,034,000 (12.96%)

Weighted Average Shares

$44,519,669 (15.59%)

$38,513,747 (35.81%)

$28,358,502 (3.68%)

$27,351,730 (11.33%)

Weighted Average Shares Diluted

$44,519,669 (15.59%)

$38,513,747 (35.81%)

$28,358,502 (3.68%)

$27,351,730 (11.33%)

Earning Before Interest & Taxes (EBIT)

-$77,578,000 (-66.17%)

-$46,687,000 (-39.21%)

-$33,536,000 (-31.73%)

-$25,459,000 (14.05%)

Gross Profit

$24,971,000 (155.27%)

$9,782,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$64,776,000 (-16.93%)

-$55,396,000 (-53.21%)

-$36,157,000 (-40.02%)

-$25,823,000 (13.73%)

SCPH Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$29,299,000 (46.75%)

$19,965,000 (143.54%)

-$45,859,000 (-242.73%)

$32,130,000 (196.03%)

Net Cash Flow from Financing

$70,080,000 (371.92%)

$14,850,000 (-80.77%)

$77,229,000 (3152.53%)

-$2,530,000 (-104.19%)

Net Cash Flow from Operations

-$70,538,000 (-19.06%)

-$59,244,000 (-71.34%)

-$34,577,000 (-27.35%)

-$27,151,000 (1.96%)

Net Cash Flow / Change in Cash & Cash Equivalents

$28,841,000 (218.06%)

-$24,429,000 (-661.74%)

-$3,207,000 (-230.95%)

$2,449,000 (404.22%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$29,320,000 (46.56%)

$20,005,000 (143.64%)

-$45,838,000 (-242.62%)

$32,139,000 (196.05%)

Capital Expenditure

-$21,000 (47.50%)

-$40,000 (-90.48%)

-$21,000 (-133.33%)

-$9,000 (0%)

Issuance (Repayment) of Debt Securities

$18,599,000 (0%)

$0 (0%)

$29,301,000 (1272.04%)

-$2,500,000 (-212.50%)

Issuance (Purchase) of Equity Shares

$54,229,000 (265.18%)

$14,850,000 (-69.05%)

$47,982,000 (93982.35%)

$51,000 (-99.92%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,442,000 (12.07%)

$4,856,000 (71.11%)

$2,838,000 (19.95%)

$2,366,000 (18.30%)

Depreciation Amortization & Accretion

$148,000 (-76.36%)

$626,000 (33.76%)

$468,000 (6.85%)

$438,000 (9.77%)

SCPH Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

68.70% (-4.58%)

72.00%

-

-

Profit Margin

-234.40% (41.87%)

-403.20%

-

-

EBITDA Margin

-213.10% (37.12%)

-338.90%

-

-

Return on Average Equity (ROAE)

-437.50% (-350.10%)

-97.20% (-27.56%)

-76.20% (-79.29%)

-42.50% (-7.32%)

Return on Average Assets (ROAA)

-90.50% (-82.46%)

-49.60% (-1.22%)

-49.00% (-57.56%)

-31.10% (-4.01%)

Return on Sales (ROS)

-213.50% (37.85%)

-343.50%

-

-

Return on Invested Capital (ROIC)

-104.10% (-84.25%)

-56.50% (50.87%)

-115.00% (6.43%)

-122.90% (-121.04%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.85 (58.03%)

-4.42 (19.95%)

-5.51 (-12.05%)

-4.92 (-21.89%)

Price to Sales Ratio (P/S)

4.34 (-75.58%)

17.77

-

-

Price to Book Ratio (P/B)

13.3 (120.15%)

6.04 (122.42%)

2.72 (11.68%)

2.43 (38.26%)

Debt to Equity Ratio (D/E)

7.07 (359.52%)

1.54 (115.24%)

0.71 (78.75%)

0.4 (22.32%)

Earnings Per Share (EPS)

-1.91 (-34.51%)

-1.42 (-9.23%)

-1.3 (-27.45%)

-1.02 (22.14%)

Sales Per Share (SPS)

0.82 (131.16%)

0.35 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.58 (-2.99%)

-1.54 (-26.15%)

-1.22 (-22.86%)

-0.99 (11.89%)

Book Value Per Share (BVPS)

0.3 (-69.05%)

0.97 (-62.18%)

2.55 (23.68%)

2.06 (-38.25%)

Tangible Assets Book Value Per Share (TABVPS)

2.42 (-1.55%)

2.45 (-43.98%)

4.38 (51.52%)

2.89 (-34.88%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (60.00%)

-5 (0.00%)

-5 (-66.67%)

-3 (25.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.13 (57.25%)

-4.99 (0.58%)

-5.01 (-60.91%)

-3.12 (24.30%)

Asset Turnover

0.39 (213.82%)

0.12 (0%)

0 (0%)

0 (0%)

Current Ratio

7.12 (0.55%)

7.08 (-57.44%)

16.63 (215.38%)

5.27 (-54.43%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$70,559,000 (-19.02%)

-$59,284,000 (-71.35%)

-$34,598,000 (-27.39%)

-$27,160,000 (1.92%)

Enterprise Value (EV)

$164,985,074 (-28.15%)

$229,616,316 (38.47%)

$165,819,375 (112.67%)

$77,969,379 (-35.18%)

Earnings Before Tax (EBT)

-$85,148,000 (-55.35%)

-$54,810,000 (-48.79%)

-$36,838,000 (-31.40%)

-$28,034,000 (12.96%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$77,430,000 (-68.10%)

-$46,061,000 (-39.29%)

-$33,068,000 (-32.16%)

-$25,021,000 (14.38%)

Invested Capital

$96,550,000 (29.08%)

$74,800,000 (-9.78%)

$82,904,000 (1023.97%)

$7,376,000 (-84.61%)

Working Capital

$90,973,000 (14.00%)

$79,804,000 (-31.14%)

$115,892,000 (82.71%)

$63,429,000 (-35.61%)

Tangible Asset Value

$107,519,000 (13.80%)

$94,479,000 (-23.93%)

$124,195,000 (57.14%)

$79,037,000 (-27.52%)

Market Capitalization

$177,142,074 (-21.22%)

$224,845,316 (14.31%)

$196,702,375 (43.24%)

$137,324,379 (-4.98%)

Average Equity

$19,461,250 (-65.49%)

$56,399,500 (16.65%)

$48,348,250 (-26.78%)

$66,034,500 (-18.76%)

Average Assets

$94,125,000 (-14.84%)

$110,530,500 (47.06%)

$75,162,500 (-16.60%)

$90,119,000 (-16.25%)

Invested Capital Average

$74,519,250 (-9.89%)

$82,694,500 (183.55%)

$29,164,000 (40.73%)

$20,723,250 (-61.12%)

Shares

50,040,134 (39.54%)

35,860,497 (30.72%)

27,434,083 (0.29%)

27,355,454 (0.13%)